红花黄色素对乳腺癌细胞增殖和迁移的抑制作用及其分子机制

孔祥东; 袁绍峰; 潘良明; 曾林文; 吴鸣; 沈建良

红花黄色素对乳腺癌细胞增殖和迁移的抑制作用及其分子机制

上海市金山区亭林医院外科

基金项目:

基金：上海市金山区卫生系统“优秀青年人才”培养计划基金资助项目 (JSYQ201620); 上海市金山区科学技术创新基金资助项目 (2015-3-24); 上海市金山区医疗卫生学科建设基金资助项目 (JSZK2015B06);

计量
- 文章访问数: 2293
- HTML全文浏览量: 838
- PDF下载量: 115
- 被引次数: 0
出版历程
- 收稿日期: 2017-05-21

The Suppressive Effect of Carthamin Yellow on the Proliferation and Migration of Human Breast Cancer Cells and Its Related Molecular Mechanisms

Funds:

摘要

摘要: 目的研究红花黄色素 (CY) 对乳腺癌细胞增殖、凋亡、迁移和侵袭的影响以及相关的分子机制.方法采用CCK-8法检测不同浓度和时间红花黄色素对人乳腺癌细胞MDA-MB-231的抑制作用;采用流式细胞术检测不同浓度红花黄色素对人乳腺癌细胞MDA-MB-231的促凋亡作用;采用Transwell法检测不同浓度红花黄色素对人乳腺癌细胞MDA-MB-231迁移和侵袭的影响;在不同浓度的红花黄色素的干预后, 通过western blot技术检测凋亡相关蛋白Cleaved-Caspase-3和生存相关蛋白p-Akt以及转移相关蛋白MMP2的表达.结果 (1) 红花黄色素对乳腺癌细胞的抑制作用具有浓度依赖性和时间依赖性; (2) 不同浓度的红花黄色素干预能显著促进乳腺癌细胞的凋亡 (P<0.01) ; (3) 不同浓度的红花黄色素干预能显著抑制p-Akt的表达并同时促进Cleaved-Caspase-3的表达; (4) 不同浓度的红花黄色素能够显著抑制乳腺癌细胞的迁移和侵袭能力 (P<0.01) , 并且能够抑制迁移相关蛋白MMP2的表达.结论红花黄色素能在体外通过激活凋亡通路而促进凋亡, 并能通过抑制MMP2来抑制乳腺癌细胞的转移.红花黄色素是一种潜在的治疗乳腺癌的药物.
- 红花黄色素 /
- 乳腺癌细胞 /
- 增殖 /
- 凋亡 /
- 迁移和侵袭
Abstract: Objective To study the effect of Carthamin Yellow (CY) on cell proliferation, apoptosis, migration and invasion ability of breast cancer and its related molecular mechanisms. Methods CCK-8 assay was used to detect cell viability of MDA-MB-231 human breast cancer cells by different concentrations of CY at different time;flow cytometry was used to test the apoptosis rate of MDA-MB-231 cells treated by different concentrations of CY and transwell assay was used to investigate the effect of various concentrations of CY on MDA-MB-231 cell migration and invasion.After the intervention of different concentrations of CY on MDA-MB-231 cells, apoptosis-related protein Cleaved-Caspase-3, survival protein p-Akt and metastasis-related protein MMP2 were detected by western blot. Results (1) CY could inhibit the proliferation of MDA-MB-231 cells in a dose-andtime-dependent manner. (2) CY significantly promoted the apoptosis of breast cancer cells (P<0.01) . (3) CY could decrease the expression of p-Akt and increase the expression of Cleaved-Caspase-3. (4) CY impaired migration and invasion of MDA-MB-231 cells (P<0.01) , and can inhibit the expression of MMP2. Conclusion CY could promote the apoptosis of breast cancer cells through activation of apoptosis signaling, and can inhibit breast cancer cell metastasis by suppressing MMP2. And CY may be a potential therapeutic drug for human breast cancer.
- Carthamin Yellow /
- Breast cancer cell /
- Proliferation /
- Apoptosis /
- Migration and invasion

HTML全文

参考文献(27)

[1]	[1]MASUDA N, LEE S J, OHTANI S, et al.Adjuvant capecitabine for breast cancer after preoperative chemotherapy[J].N Engl J Med, 2017, 376 (22) :2147-2159.
[2]	[2]DENGFENG L I, JIASHU H U, HONGMING SONG, et al.mi R-143-3p targeting LIM domain kinase 1 suppresses the progression of triple-negative breast cancer cells[J].Am J Transl Res, 2017, 9 (5) :2276-2285.
[3]	[3]ZHIHAO ZENG, XIAOWU CHEN, DAJIAN ZHU, et al.Low expression of circulating micro RNA-34c is associated with poor prognosis in triple-negative breast cancer[J].Yonsei Med J, 2017, 58 (4) :697-702.
[4]	[4]XUE WANG, NAN ZHENG, JING DONG, et al.Estrogen receptor-alpha36 is involved in icaritin induced growth inhibition of triple-negative breast cancer cells[J].J Steroid Biochem Mol Biol, 2017, 171 (7) :318-327.
[5]	[5]DESHENG LIANG, WENJIE ZHANG, AITING WANG, et al.Treating metastatic triple negative breast cancer with CD44/neuropilin dual molecular targets of multifunctional nanoparticles[J].Biomaterials, 2017, 137 (5) :23-36.
[6]	[6]YUN CAI, BOXIN ZHAO, QIANYING LIANG, et al.The selective effect of glycyrrhizin and glycyrrhetinic acid on topoisomerase IIalpha and apoptosis in combination with etoposide on triple negative breast cancer MDA-MB-231cells[J].Eur J Pharmacol, 2017, 809 (8) :87-97.
[7]	[7]HAMER J, WARNER W.Lifestyle modifications for patients with breast cancer to improve prognosis and optimize overall health[J].Cmaj, 2017, 189 (7) :E268-e274.
[8]	[8]LIBING ZHU, LINGRU L I, YINGSHUAI LI, et al.Chinese herbal medicine as an adjunctive therapy for breast cancer:A systematic review and meta-analysis[J].Evid Based Complement Alternat Med, 2016, (18, supplement) :9469276.
[9]	[9]CHINGCHIUNG WANG, CHEUKSING CHOY, YUNGHUNG LIU, et al.Rotective effect of dried safflower petal aqueous extract and its main constituent, carthamus yellow, against lipopolysaccharide-induced inflammation in RAW264.7 macrophages[J].J Sci Food Agric, 2011, 91 (2) :218-25.
[10]	[10]SIYUAN FAN, NAN LIN, GUANGLIANG SHAN, et al.Safflower yellow for acute ischemic stroke:A systematic review of randomized controlled trials[J].Complement Ther Med, 2014, 22 (2) :354-61.
[11]	[11]TAKAHASHI Y, MIYASAKA N, TASAKA S, et al.Constitution of two coloring matters in the flower petals of Carthamus Tinctorius L[J].Tetrahedron Letters, 1982, 23 (49) :5163-5166.
[12]	[12]MINXIN ZHOU, JIANHUA F U, QIONG ZHANG, et al.Effect of hydroxy safflower yellow A on myocardial apoptosis after acute myocardial infarction in rats[J].Genet Mol Res, 2015, 14 (2) :3133-3341.
[13]	[13]XIUGUO HAN, LIN DU, HAN QIAO, et al.CXCR1knockdown improves the sensitivity of osteosarcoma to cisplatin[J].Cancer Lett, 2015, 369 (2) :405-415.
[14]	[14]JINGJING SONG, YINGWU WANG, MEIYU TENG, et al.Cordyceps militaris induces tumor cell death via the caspasedependent mitochondrial pathway in Hep G2 and MCF7 cells[J].Mol Med Rep, 2016, 13 (6) :5132-5140.
[15]	[15]LEE W H, CHOONG L Y, JIN T H, et al.TRPV4 plays a role in breast cancer cell migration via Ca2+-dependent activation of AKT and downregulation of E-cadherin cell cortex protein[J].Oncogenesis, 2017, 6 (5) :e338.
[16]	[16]JINGYI L I, QIAN ZENG, YIXIN ZHANG, et al.Neurokinin-1 receptor mediated breast cancer cell migration by increased expression of MMP-2 and MMP-14[J].Eur J Cell Biol, 2016, 95 (10) :368-377.
[17]	[17]XICHUN HU, WEI HUANG, MINHAO FAN, Emerging therapies for breast cancer[J].J Hematol Oncol, 2017.10 (1) :98.
[18]	[18]YI ZHANG, XU SUN, NAN NAN, et al.Elemene inhibits the migration and invasion of 4T1 murine breast cancer cells via heparanase[J].Mol Med Rep, 2017, 16 (1) :794-800.
[19]	[19]JIAN CHEN, JIEHUI TENG, LI M A, et al.Flavonoids isolated from the flowers of limonium bicolor and their in vitro antitumor evaluation[J].Pharmacogn Mag, 2017, 13 (50) :222-225.
[20]段培锋, 贾秀红, 王建勇.红花注射液对白血病HEL细胞增殖和凋亡的影响及相关机制探讨[J].中国当代儿科杂志, 2015, 17 (9) :989-993.
[21]	[21]JIANYING L I, JUN Y U, XUSHENG D U, et al.Safflower polysaccharide induces NSCLC cell apoptosis by inhibition of the Akt pathway[J].Oncol Rep, 2016, 36 (1) :147-154.
[22]	[22]XIUGUO HAN, YAN L I, HUIMIN M O, et al.TIMP3regulates osteosarcoma cell migration, invasion, and chemotherapeutic resistances[J].Tumour Biol, 2016, 37 (7) :8857-8867.
[23]	[23]HONGYU SHEN, LIANGPENG LI, SUJIN YANG, et al.Micro RNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3beta signaling pathway[J].Gene, 2016, 593 (1) :84-90.
[24]	[24]JIAYUN LIU, XIAOYU W U, GUANNAN W U, et al.FOXQ1 promotes cancer metastasis by PI3K/AKT signaling regulation in colorectal carcinoma[J].Am J Transl Res, 2017, 9 (5) :2207-2218.
[25]	[25]CHA H J, CHOI J H, PARK I C et al.Selective FGFR inhibitor BGJ398 inhibits phosphorylation of AKT and STAT3 and induces cytotoxicity in sphere-cultured ovarian cancer cells[J].Int J Oncol, 2017, 50 (4) :1 279-1 288.
[26]	[26]MENDES O, KIM H T, LUNGU G, et al.MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2[J].Clin Exp Metastasis, 2007, 24 (5) :341-351.
[27]	[27]BO LIU, JIAN CUI, JING SUN, et al.Immunolocalization of MMP9 and MMP2 in osteolytic metastasis originating from MDA-MB-231 human breast cancer cells[J].Mol Med Rep, 2016, 14 (2) :1 099-11 06.

相关文章(20)

[1]	杨少华, 许永平, 赵棁预, 方兴保, 阮振兴. EIF5A1通过Wnt/β-Catenin信号通路促进肝内胆管癌细胞增殖和迁移侵袭, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20250706
[2]	王玲, 秦祥川, 李金秋, 阿仙姑·哈斯木. CD147通过AIM2炎症小体介导宫颈癌细胞焦亡和增殖, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240103
[3]	秦祥川, 李金秋, 黄晓婧, 忽吐比丁·库尔班, 阿仙姑·哈斯木. HPV E6通过Rap1信号通路影响宫颈癌细胞增殖、侵袭及迁移的研究, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240902
[4]	李妍平, 董小林, 李青芸, 李红梅, 魏欢, 曾毅. miR-21-5p通过抑制STAT3缓解OGD诱导的HT22细胞炎症和凋亡并促进增殖, 昆明医科大学学报.
[5]	刘邦卿, 李剑锋, 刘晓辉, 张劲男, 梁金屏. miR-196b靶向ERG促进肺腺癌的增殖和迁移, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20231023
[6]	胡滔, 吴怡, 耿文达, 章意坚, 贺瑄, 李珊珊, 习杨彦彬, 邓丽玲. 自主运动训练通过调节Caspase-3的活性抑制人BRCA1突变乳腺癌的增殖与生长, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230419
[7]	张晔琳, 马丽娅, 彭旭晖, 杨禾丰, 佘睿. hsa-let-7a-5p调控牙周膜干细胞增殖及凋亡, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20231028
[8]	张梁, 王保全, 雷喜锋, 王旭, 柯阳, 张玮. miR-29c-3p/IGF1分子轴对肝星状细胞活化，增殖和凋亡的作用机制, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230926
[9]	张玮, 王保全, 雷喜锋, 王旭, 张梁. miR-125b-5p调控HK2抑制胆囊癌细胞增殖和糖酵解, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20221206
[10]	廖周俊, 杨少华, 刘立鑫, 胡晟, 陈轶晖, 康强, 张小文. AK4对肝内胆管癌细胞HUCCT1增殖、迁移的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220611
[11]	赵斌, 段元鹏, 张国颖, 毕城伟, 杨李波, 施致裕, 杨勇, 张建朋, 高婷. CircRNA EZH2通过调控miR-30c-5p促进前列腺癌细胞增殖和迁移, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220731
[12]	孙健玮, 向茜, 刘子超, 徐珊珊, 丁丁. PTEN基因表达对甲状腺癌BCPAP和FTC133细胞凋亡以及ERK和AKT表达的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210805
[13]	杨兰, 贾霄, 姜奕彤, 崔琪, 刘光赐, 何颖红. UBE2C基因沉默表达对人胃癌AGS细胞增殖和迁移的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210504
[14]	戈佳云. 慢病毒介导的FHIT基因过表达调控人肝癌细胞株生长实验研究, 昆明医科大学学报.
[15]	刘立鑫. 二甲双胍对肝癌细胞HCCLM3生物学行为的影响, 昆明医科大学学报.
[16]	白宇. 小白菊内酯在人膀胱癌T24细胞中抑制增殖和诱导凋亡的作用, 昆明医科大学学报.
[17]	王海峰. 上调microRNA-101沉默EZH2基因表达对人膀胱癌T24细胞系增殖和凋亡的影响, 昆明医科大学学报.
[18]	刘佳鑫. SDF-1/CXCR4在恶性胶质瘤细胞体外增殖、迁移及侵袭中的作用, 昆明医科大学学报.
[19]	夏英杰. SD大鼠髁状突颈部骨折对大鼠髁状突软骨细胞增殖与凋亡的影响, 昆明医科大学学报.
[20]	李振. 多发性硬化患者外周血Annexin V结合T淋巴细胞凋亡和Fas的表达, 昆明医科大学学报.